Back
ANKRD11HGNC Autosomal dominantPubMedPhenotypic expansion

Insights into ANKRD11-related epilepsy from 163 people

Su S, Ma J, Zhang Q, et al.Epilepsia 2026 · June 2026
Relevance score
7/10
Disease / domain
KBG syndrome / ANKRD11-related epilepsy
Source
PubMed
PMID 42322264
Share on LinkedIn

Variant / mechanism

Heterozygous *ANKRD11* variants causing epilepsy with genotype-phenotype correlations by molecular domain

Summary

An integrated cohort of 163 individuals with ANKRD11 variants and epilepsy defines the phenotypic spectrum of epilepsy in KBG syndrome. Seizures appear at a median age of 4 years, with equal representation of focal and generalized epilepsies and absences in 22.8% of cases. Truncating variants predominate (60.1%) and missense variants cluster in the RD2 repression domain, associated with later onset and better seizure control. 36.8% present drug-resistant epilepsy.

Synthesis written by Geno'X. For the full original abstract, please refer to the source publication.

Analysis

The largest published series on ANKRD11-related epilepsy provides genotype-phenotype data usable in genetic counseling. The correlation between RD2 domain localization and milder epileptic phenotype is immediately clinically useful. Drug-resistant epilepsy in over a third of cases underscores the potential severity of this phenotype.

Why this score?

Impact 2/3Evidence 2/3Novelty 1/2Sample 1/1Publication 1/1

Clinical impact: 2/3 · Evidence strength: 2/3 · Novelty: 1/2 · Sample size: 1/1 · Publication status: 1/1 → Total: 7/10

Keywords

ANKRD11KBG syndromeepilepsyneurodevelopmentintellectual disability
Weekly report in your inbox

Every Wednesday · Annotated selection · Free · Unsubscribe anytime